Jamie V. Shaw
Winnipeg, MB, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Lupus Nexus: developing a prospective registry, biorepository and data exchange platform to foster global collaborations, accelerate research innovation and advance precision medicine in lupus.
Journal: Lupus science & medicine
Published: March 26, 2026
Pursuitworthiness in science.
Journal: Studies in history and philosophy of science
Published: January 13, 2026
Microvascular Inflammation in Kidney Transplantation.
Journal: Journal of the American Society of Nephrology : JASN
Published: January 09, 2026
Corrigendum to "HLA-DQ heterodimer mismatch as a predictor of post-transplant alloimmunity and allograft survival". [Hum. Immunol. 86 (2025) 111345].
Journal: Human immunology
Published: July 27, 2025
Enpatoran, a first-in-class, selective, orally administered toll-like receptor 7/8 inhibitor, in systemic and cutaneous lupus erythematosus: results from a randomised, placebo-controlled phase Ib study.
Journal: Lupus science & medicine
Published: June 12, 2025
HLA-DQ heterodimer mismatch as a predictor of post-transplant alloimmunity and allograft survival.
Journal: Human immunology
Published: February 11, 2025
Toll-like receptor 8 activation induces a neutrophil inflammatory phenotype: therapeutic implications for the utility of toll-like receptor 8 inhibition.
Journal: Journal of leukocyte biology
Published: December 05, 2024
Efficacy and safety results after >3.5 years of treatment with the Bruton's tyrosine kinase inhibitor evobrutinib in relapsing multiple sclerosis: Long-term follow-up of a Phase II randomised clinical trial with a cerebrospinal fluid sub-study.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: March 04, 2024
Asia-Inclusive Global Development of Enpatoran: Results of an Ethno-Bridging Study, Intrinsic/Extrinsic Factor Assessments and Disease Trajectory Modeling to Inform Design of a Phase II Multiregional Clinical Trial.
Journal: Clinical pharmacology and therapeutics
Published: November 07, 2023
A rational approach to guide cost-effective de novo donor-specific antibody surveillance with tacrolimus immunosuppression.
Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Published: May 12, 2023
Last Updated: 09/26/2026